INO going LONGAs a disclosure I am quite new to reading charts, but i have been learning. In this chart you can see that the consolidation of the highs and lows are funneling towards $13 a share. But keep in mind that a failing testing procedure can break the lows into a new support line. As the earnings are coming up, we may find a price rally.
INO trade ideas
INO INO INOThe elliot is not really valid , but it helps me to see clear wave movement.
INO is news based stock, High risk high reward. as long as it stays in the race for vaccine , it should be fine, but one bad news of failure can take it down to $2.
That race can last for months to come, so there is opportunity
I traded it few times and it works well with Fibs.
It was recently downgraded, which reflected in a drop. Very easy to manipulate.
Its still in a daily uptrend.
My entry level would be around 9.15 (could enter at $10 if it holds)
My target would be $13 with 60% of my position and $15 with the rest
Short volume has been lowered in past few days, so $10 can be the bottom
If it brakes those levels then look for next support at 6.90
Good luck
INO Still in the running for uptrend to earningsWith a vaccine in trials and also being one of the first, it's looking pretty good for the small company.
Only up from here. They are also working on HPV treatments.
Although smaller than the majors, being so small gives a lot of room for movement.
Check my previous post about INO. Tomorrow will confirm an uptrend into earnings for me. Not necessarily a large income generator but for the time being will definitely rise to the occasion.
INO Up 10%After Hours On Virus Info - See Our Short BelowINO is up 10% after hours on virus info - we will be looking to SHORT this name tomorrow in the following manner by selling a Weekly Call Credit Spread
re sell the 18 call buy the 19 or 17/18 pick your poison we will probably go even a bit further out for less premium - if you don't know what you're doing DO NOT DO THIS TRADE and as always not advice.
Inovio, not profitable, overbought, highly speculative. www.fool.com
citronresearch.com
Inovio currently has no products on the market! It is not making any money. All their efforts and promises ended up with no effects so far in the last 10 years at least. Fundamentals are screaming to short this stock. It is overbought and all similar setups ended up the same way for this company.
Not too late to buy INO(maybe MOON)Possible pull back reasons:
BTC halving: Millenials are into crypto and a lot of people made money June last year before the LTC halving. People are hyped because this is the last major halving for 4 years. And might be selling their stocks or fresh INO gains to get into BTC. PLUS miners usually plan ahead for the bitcoin halvings and buy extra equipment to not suffer any major losses. BUt CORORNAviruis might have put a stop to the equipment the miners need to keep BTC mining profitable. If that is true then we might see something close to 2017. But I expect miner had their equipment before this all happened. Or will get it in the month before the next halving.
People forget: America moves fast. if something major happens on Monday it's lucky to be stilled talked about the next Monday. So people are naturally not talking about the coronaviruis and people might care less and less about the vaccine by the time it is ready to be sold. We are aslo seeing states open stores and businesses more and more. That will distract from a vaccine as well.
Overall, INO is into more than just a COVID19 vaccine. And I think, after some interview I've seen recently, Mad money, the CEO and the company is run with good intention and have good products. So, it could pull back but I see recovery if that happens. a pullback happening would probably take some bad press or fake news.
$INO reaches NEW HIGH$INO an early-stage biotech that is working toward a vaccine for Covid-19 should be commended for a great job. Line on the chart was doing its job as a leading indicator by making a new high before prices actually make another new high and as expected, it ready did. That prices remain in a strong uptrend. So far, earnings season has not been the obstacle that many have feared
INO- A retest to the 15's or back to 12'sI'm keeping a close eye on INO. Went long from $7 all the way to $9. I did lock profits early, but this parabolic run is something to watch for.
I'm currently holding $10 Puts On INO . If it fails to stay within $13.50-14.50 then back to 12s and then 10s, back to 9s and 8s .
However this a volatile stock, if it can hold, then we can see $16 being re tested possibly aiming for a nice squeeze to 19s and 20s .
INO - Quick TA - Lots of bullish potentialJust a quick run-through of where INO may be headed in the next four or five months based on meaningful support and resistance, as well as the current volume being driven into it. I believe we are in a change of trend from its downtrend / consolidation from the initial years of trading back in 2000, and we have now conclusively broken several layers or time and price resistance, however, we really need to see the $16 level to be broken and exceeded to see where the potential upside will land. Though, things are looking good for short term, or long term holds, in my opinion. 👍
Cheers!
Inovio: $17 to $21 short (Overvalued + Small Dip)Please remember everything I say is on the basis of opinion and not meant to be face value. That being said, Inovio pharmaceuticals is overvalued given its hugely bullish increase, but has one of the biggest growth potentials for 1 to 3 weeks. Again, this is likely a quick sale stock rather then long term. A primary reason for the quick sale would be the fact that Inovio is working on a Coronavirus related vaccine. Given this, you could expect a potentially sudden increase in price, but soon just as sudden or as deep of a decrease. That is why it would be good to invest in the dip (which slightly just passed), but still hold this for a few weeks, then reinvest much later on, when news is about to come related to clinical trials and such. That way you put less risk on a hugely bearish decrease. The post-market is already negative, but I think next few weeks Inovio still has even some growth potential in its continued bull run. It does look like this small biotech company should be on the watchlist for many investors. Though I recommend a swing strategy, this doesn't necessarily condone doing a long hold instead, but it is less risk and has better potential (in my opinion).